Studies have unraveled many aberrantly expressed genes in gastric cancer including BMI1 [5], COX-2 [6], HER3 [7], RKIP and STAT3 [8], SPARC [9] and HER2 [10,11], which make risk assessment of gastric cancer patients more accurately. This evidence concerns the gene SPARC and gastric cancer.